المؤلفون: Jain, N, Hartert, K, Tadros, S, Fiskus, W, Havranek, O, Ma, MCJ, Bouska, A, Heavican, T, Kumar, D, Deng, Q, Moore, D, Pak, C, Liu, CL, Gentles, AJ, Hartmann, E, Kridel, R, Smedby, KE, Juliusson, G, Rosenquist, R, Gascoyne, RD, Rosenwald, A, Giancotti, F, Neelapu, SS, Westin, J, Vose, JM, Lunning, MA, Greiner, T, Rodig, S, Iqbal, J, Alizadeh, AA, Davis, RE, Bhalla, K, Green, MR

المصدر: Science translational medicine. 11(497)

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:141182333

المؤلفون: Abramson, JS, Solomon, SR, Arnason, JE, Johnston, PB, Glass, B, Bachanova, V, Ibrahimi, S, Mielke, S, Mutsaers, P, Hernandez-Ilizaliturri, F, Izutsu, K, Morschhauser, F, Lunning, MA, Crotta, A, Montheard, S, Previtali, A, Kamdar, M

المصدر: BLOOD. 140:1581-1583

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:151899860

المؤلفون: Glass, B, Abramson, JS, Solomon, SR, Arnason, JE, Johnston, PB, Bachanova, Ibrahimi, S, Mielke, S, Mutsaers, P, Hernandez-Ilizaliturri, F, Izutsu, K, Morschhauser, F, Lunning, MA, Crotta, A, Montheard, S, Previtali, A, Kamdar, M

المصدر: ONCOLOGY RESEARCH AND TREATMENT. 46:272-273

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:154387108

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Eiken AP; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska., Smith AL; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska., Skupa SA; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska., Schmitz E; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska., Rana S; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska., Singh S; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska., Kumar S; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska., Mallareddy JR; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska., de Cubas AA; Department of Microbiology and Immunology, College of Medicine, Medical University of South Carolina, Charleston, South Carolina., Krishna A; Department of Genetics, Cell Biology, and Anatomy, University of Nebraska Medical Center, Omaha, Nebraska., Kalluchi A; Department of Genetics, Cell Biology, and Anatomy, University of Nebraska Medical Center, Omaha, Nebraska., Rowley MJ; Department of Genetics, Cell Biology, and Anatomy, University of Nebraska Medical Center, Omaha, Nebraska., D'Angelo CR; Division of Hematology and Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska.; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska., Lunning MA; Division of Hematology and Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska.; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska., Bociek RG; Division of Hematology and Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska.; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska., Vose JM; Division of Hematology and Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska.; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska., Natarajan A; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska.; Department of Genetics, Cell Biology, and Anatomy, University of Nebraska Medical Center, Omaha, Nebraska.; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska., El-Gamal D; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska.; Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska.

المصدر: Cancer research communications [Cancer Res Commun] 2024 May 22; Vol. 4 (5), pp. 1328-1343.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Lymphocytic, Chronic, B-Cell*/drug therapy , Leukemia, Lymphocytic, Chronic, B-Cell*/metabolism , Leukemia, Lymphocytic, Chronic, B-Cell*/pathology , Signal Transduction*/drug effects, Humans ; Animals ; Mice ; Piperidines/pharmacology ; Piperidines/therapeutic use ; Cell Line, Tumor ; Unfolded Protein Response/drug effects ; Adenine/analogs & derivatives ; Adenine/pharmacology ; Drug Resistance, Neoplasm/drug effects ; NF-kappa B/metabolism ; Spiro Compounds/pharmacology ; Spiro Compounds/therapeutic use ; Cell Survival/drug effects ; Tumor Microenvironment/drug effects ; Receptors, Antigen, B-Cell/metabolism ; Cell Proliferation/drug effects

المؤلفون: Smith AL; Eppley Institute for Research in Cancer and Allied Diseases., Skupa SA; Eppley Institute for Research in Cancer and Allied Diseases., Eiken AP; Eppley Institute for Research in Cancer and Allied Diseases., Reznicek TE; Department of Genetics, Cell Biology and Anatomy., Schmitz E; Eppley Institute for Research in Cancer and Allied Diseases., Williams N; Eppley Institute for Research in Cancer and Allied Diseases., Moore DY; Eppley Institute for Research in Cancer and Allied Diseases., D'Angelo CR; Division of Hematology and Oncology, Department of Internal Medicine, and.; Fred & Pamela Buffett Cancer Center (FPBCC), University of Nebraska Medical Center (UNMC), Omaha, Nebraska, USA., Kallam A; Division of Hematology and Oncology, Department of Internal Medicine, and.; Fred & Pamela Buffett Cancer Center (FPBCC), University of Nebraska Medical Center (UNMC), Omaha, Nebraska, USA., Lunning MA; Division of Hematology and Oncology, Department of Internal Medicine, and.; Fred & Pamela Buffett Cancer Center (FPBCC), University of Nebraska Medical Center (UNMC), Omaha, Nebraska, USA., Bociek RG; Division of Hematology and Oncology, Department of Internal Medicine, and.; Fred & Pamela Buffett Cancer Center (FPBCC), University of Nebraska Medical Center (UNMC), Omaha, Nebraska, USA., Vose JM; Division of Hematology and Oncology, Department of Internal Medicine, and.; Fred & Pamela Buffett Cancer Center (FPBCC), University of Nebraska Medical Center (UNMC), Omaha, Nebraska, USA., Mohamed E; College of Medicine and College of Graduate Studies, California Northstate University, Elk Grove, California, USA., Mahr AR; Department of Biology, University of Nebraska at Omaha, Omaha, Nebraska, USA., Denton PW; Department of Biology, University of Nebraska at Omaha, Omaha, Nebraska, USA., Powell B; Plexxikon Inc., South San Francisco, California, USA., Bollag G; Opna Bio LLC, South San Francisco, California, USA., Rowley MJ; Department of Genetics, Cell Biology and Anatomy., El-Gamal D; Eppley Institute for Research in Cancer and Allied Diseases.; Fred & Pamela Buffett Cancer Center (FPBCC), University of Nebraska Medical Center (UNMC), Omaha, Nebraska, USA.

المصدر: JCI insight [JCI Insight] 2024 May 22; Vol. 9 (10). Date of Electronic Publication: 2024 May 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Lymphocytic, Chronic, B-Cell*/immunology , Leukemia, Lymphocytic, Chronic, B-Cell*/drug therapy , Tumor Microenvironment*/immunology , Tumor Microenvironment*/drug effects , T-Lymphocytes*/immunology , T-Lymphocytes*/drug effects , T-Lymphocytes*/metabolism, Humans ; Animals ; Mice ; Transcription Factors/metabolism ; Transcription Factors/genetics ; Hepatocyte Nuclear Factor 1-alpha/metabolism ; Hepatocyte Nuclear Factor 1-alpha/genetics ; Cell Proliferation/drug effects ; Bromodomain Containing Proteins ; Proteins

المؤلفون: Elsallab M; Harvard-MIT Center for Regulatory Science, Harvard Medical School, Boston, MA.; Cellular Immunotherapy Program, Mass General Cancer Center, and Department of Medicine, Harvard Medical School, Boston, MA., Ellithi M; Fred & Pamela Buffett Cancer Center, Division of Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE., Lunning MA; Fred & Pamela Buffett Cancer Center, Division of Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE., D'Angelo C; Fred & Pamela Buffett Cancer Center, Division of Hematology-Oncology, University of Nebraska Medical Center, Omaha, NE., Ma J; Department of Biostatistics, University of Nebraska Medical Center, Omaha, NE., Perales MA; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY., Frigault M; Cellular Immunotherapy Program, Mass General Cancer Center, and Department of Medicine, Harvard Medical School, Boston, MA., Maus MV; Cellular Immunotherapy Program, Mass General Cancer Center, and Department of Medicine, Harvard Medical School, Boston, MA.

المصدر: Blood [Blood] 2024 May 16; Vol. 143 (20), pp. 2099-2105.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms, Second Primary*/etiology , Neoplasms, Second Primary*/therapy , Neoplasms, Second Primary*/epidemiology , United States Food and Drug Administration* , Immunotherapy, Adoptive*/adverse effects , Adverse Drug Reaction Reporting Systems*, Humans ; United States/epidemiology ; Male ; Receptors, Chimeric Antigen/immunology ; Female ; Middle Aged ; Adult ; Aged

المؤلفون: Lunning MA; University of Nebraska, Omaha, Nebraska, USA., Wang HL; Kite, A Gilead Company, Santa Monica, California, USA., Hu ZH; Kite, A Gilead Company, Santa Monica, California, USA., Locke FL; Moffitt Cancer Center, Tampa, Florida, USA., Siddiqi T; City of Hope National Medical Center, Duarte, California, USA., Jacobson CA; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Ahmed S; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Miklos DB; Stanford University School of Medicine, Stanford, California, USA., Lin Y; Mayo Clinic, Rochester, Minnesota, USA., Hill BT; Cleveland Clinic Foundation, Cleveland, Ohio, USA., Ghobadi A; Washington University School of Medicine, St Louis, Missouri, USA., Neelapu SS; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Westin J; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Dieyi C; Kite, A Gilead Company, Santa Monica, California, USA., Field P; Oxford PharmaGenesis, Oxford, UK., Miao H; Kite, A Gilead Company, Santa Monica, California, USA., Shahani SA; Kite, A Gilead Company, Santa Monica, California, USA., Patel A; Kite, A Gilead Company, Santa Monica, California, USA., Spooner C; Kite, A Gilead Company, Santa Monica, California, USA., Fu C; Kite, A Gilead Company, Santa Monica, California, USA., Muramoto D; Kite, A Gilead Company, Santa Monica, California, USA., Xu H; Kite, A Gilead Company, Santa Monica, California, USA., Pasquini MC; CIBMTR, Milwaukee, Wisconsin, USA.

المصدر: American journal of hematology [Am J Hematol] 2024 May; Vol. 99 (5), pp. 880-889. Date of Electronic Publication: 2024 Mar 19.

نوع المنشور: Observational Study; Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Large B-Cell, Diffuse*/drug therapy , Biological Products*/therapeutic use, Humans ; Aged ; Retrospective Studies ; Pathologic Complete Response ; Immunotherapy, Adoptive ; Antigens, CD19

المؤلفون: Rezazadeh A; Medical College of Wisconsin., Szabo A; Medical College of Wisconsin., Khurana A; Mayo Clinic., Inwards DJ; Mayo Clinic., Lunning MA; University of Nebraska., Bartlett NL; Washington University., Caimi PF; Case Western., Rodgers TD; University of Rochester., Barr PM; University of Rochester., Chowdhury SM; Ohio State University., Epperla N; Ohio State University., Mendries H; Cleveland Clinic., Hill BT; Cleveland Clinic., Oh TS; Northwestern University., Karmali R; Northwestern University., Chang JE; University of Wisconsin-Madison., Goyal G; University of Alabama-Birmingham., Parsons BM; Gundersen Health System., Isaac KM; University of Virginia., Portell CA; University of Virginia., Monahan K; Medical College of Wisconsin., Siker M; Medical College of Wisconsin., King DM; Medical College of Wisconsin., Fenske TS; Medical College of Wisconsin. tfenske@mcw.edu.

المصدر: Haematologica [Haematologica] 2024 May 01; Vol. 109 (5), pp. 1439-1444. Date of Electronic Publication: 2024 May 01.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Large B-Cell, Diffuse*/mortality , Lymphoma, Large B-Cell, Diffuse*/drug therapy , Lymphoma, Large B-Cell, Diffuse*/therapy , Lymphoma, Large B-Cell, Diffuse*/pathology , Rituximab*/therapeutic use , Rituximab*/administration & dosage, Humans ; Retrospective Studies ; Male ; Female ; Middle Aged ; Aged ; Adult ; Neoplasm Staging ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Bone Neoplasms/mortality ; Bone Neoplasms/drug therapy ; Bone Neoplasms/pathology ; Bone Neoplasms/therapy ; Treatment Outcome ; Aged, 80 and over